John Libbey Eurotext

European Journal of Dermatology


Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care Volume 30, numéro 3, May-June 2020


  • Figure 1
  • Figure 2


1 Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, D-20246 HamburgGermany
2 Psoriasis-Centre, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105 KielGermany
3 Institute and Comprehensive Center Inflammation Medicine, University of Lübeck, Ratzeburger Allee 160, 23538 LübeckGermany
4 Division of Dermatology and Venereology, Geneva University Hospitals, Rue Gabrielle Perret-Gentil 4, 1205 GenevaSwitzerland
* Reprints


Psoriasis may cause considerable disease burden. The involvement of sexually-sensitive/visible body areas has been associated with decreased quality of life (QoL), more depressive symptoms and stigmatisation experiences.